http://www.7x7health.com Health News Sat, 15 Nov 2008 21:03:33 +0000 http://backend.userland.com/rss092 en Zannos Grekos, MD presented clinical data this week to the Dubai Congress on Regenerative Biomedical Technologies demonstrating the successful treatment of end-stage cardiac diseases using Autologous Adult Stem Cell Therapy. Dr. Grekos offered cardiac nuclear scans, PET scans, and echocardiographs performed at six months and one year post-treatment, which confirm ... http://www.7x7health.com/2008/11/15/successful-treatment-of-cardiovascular-disease-using-stem-cells/44 Dr. Bonnie Vulich, owner and medical director at Refine Medical Spa in Chicago is helping her clients have the body they've always wanted by eliminating areas of unwanted fat with a new FDA approved procedure called Smart Lipo. SmartLipo is laser-assisted lipolysis also known as laser body sculpting. On Tuesday, November ... http://www.7x7health.com/2008/11/10/revolutionary-alternative-to-liposuction-that-permanently-melts-away-fat/41 SunTech Medical launches the Advantage™ A+ OEM Non-invasive Blood Pressure (OEM NIBP) module. Designed with an array of next-generation features, the Advantage A+ is the smallest, most complete module in its class. “As the market leader in providing OEM blood pressure technology to medical equipment manufacturers, we are excited to release ... http://www.7x7health.com/2008/10/20/suntech-medical-introduces-next-generation-of-oem-nibp-module/39 Anadis Ltd. (ASX:ANX; OTC:ANDIY) an Australian biopharmaceutical company specializing in oral immunotherapy using naturally derived antibodies and other proteins is announcing the clinical protocol for its Cancer-related Mucositis Program was cleared by the Tel Aviv Souraski Medical Center’s Institutional Review Board (IRB) and by the Israeli Ministry of Health (MOH). ... http://www.7x7health.com/2008/09/04/clinical-trial-protocol-against-cancer-therapy-side-effects-mucositis-approved/37 Most patients facing surgery to correct a painful spinal condition are usually a bit apprehensive. Not so for 70-year-old Marveen Boone of Chase, Louisiana, who will become the first patient in the United States to surgically receive a new investigational device. The VertiFlex Superion Interspinous Spacer is a small spacing ... http://www.7x7health.com/2008/06/26/investigational-device-for-patients-with-lumbar-spinal-stenosis/35 The Neutrogena Partnership for Skin Health, a public service initiative that partners with organizations and individuals to educate, promote advancements and explore solutions for skin health, has tapped actress Malin Akerman to educate consumers in a viral video about self-examination for skin cancer detection. As the #1 dermatologist recommended skincare ... http://www.7x7health.com/2008/06/26/neutrogena-partnership-for-skin-health-taps-malin-akerman-to-educate-about-skin-cancer-detection/32 The Scots have been known for centuries to be able to make the impossible happen. From Robert the Bruce to William Wallace, facing the challenge and winning is the only option. So when you get two good friends having a late night dram of The Glenlivet single malt scotch in ... http://www.7x7health.com/2008/06/25/scotsmen-set-out-to-raise-awareness-of-rare-syndrome-on-a-journey-across-america/31 Determined to help lift the spirits of seriously ill children and their families, Nintendo of America Inc. and Starlight Starbright Children’s Foundation have committed to placing hundreds of popular Fun Centers, now featuring Wii game systems, in hospitals across the United States and Canada by the end of this year. ... http://www.7x7health.com/2008/06/25/nintendo-and-starlight%e2%80%99s-new-fun-centers-featuring-wii-give-sick-children-a-boost/28 Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience. The research, an important step toward developing new treatments for stroke, ... http://www.7x7health.com/2008/06/25/nerve-cells-derived-from-embryonic-stem-cells-and-transplanted-into-mice-may-lead-to-improved-brain-treatments/27 The U.S. Food and Drug Administration has cleared for marketing a new safety engineered short-term peripheral Intra-Venous (IV) Catheter. The product, VantageCath, is designed to significantly reduce exposure to bloodborne pathogens during the placement of the catheter and also provide the clinician with desirable feature sets. Existing safety engineered peripheral IVs ... http://www.7x7health.com/2008/05/05/advantage-medical-devices-receives-fda-clearance-for-vantagecath/26